Codeine-6-glucuronide
Codeine-6-glucuronide
Codeine-6-glucuronide is a major metabolite of the opioid analgesic codeine. It is formed in the liver through the process of glucuronidation, which is a common pathway for the metabolism of many drugs. This process involves the addition of a glucuronic acid moiety to codeine, making it more water-soluble and facilitating its excretion from the body.
Formation and Metabolism
Codeine-6-glucuronide is produced by the action of the enzyme UDP-glucuronosyltransferase (UGT), specifically UGT2B7, on codeine. This reaction occurs primarily in the liver, where codeine is converted into its glucuronide form. The formation of codeine-6-glucuronide is an important step in the metabolism of codeine, as it represents a significant portion of the drug's metabolic pathway.
Pharmacological Activity
While codeine itself is a weak opioid, its metabolites, including codeine-6-glucuronide, contribute to its analgesic effects. Codeine-6-glucuronide has been shown to possess opioid activity, although its exact contribution to the overall effects of codeine is still a subject of research. It is believed to have a higher affinity for opioid receptors compared to codeine, which may enhance its analgesic properties.
Excretion
The increased water solubility of codeine-6-glucuronide allows it to be readily excreted by the kidneys. This metabolite is eliminated from the body through the urine, which is a common route for the excretion of glucuronidated compounds. The excretion of codeine-6-glucuronide is an important factor in the clearance of codeine from the body.
Clinical Significance
Understanding the metabolism of codeine to codeine-6-glucuronide is important in clinical settings, particularly in the context of pain management and opioid pharmacology. Variations in the activity of UGT enzymes can affect the levels of codeine-6-glucuronide, influencing the efficacy and safety of codeine as a medication. Additionally, genetic polymorphisms in UGT2B7 may lead to differences in drug metabolism among individuals.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD